EcoDrugPlus

Phosphodiesterase 4d

Ensembl ID : ENSSTUG00000006283
Gene Symbol: PDE4D
1 Cross references
213 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSSTUG00000031450
Gene Symbol: PDE5A
3 Cross references
217 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSSTUG00000050652
Gene Symbol: PDE7A
3 Cross references
169 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSSTUG00000022435
Gene Symbol: PDE7A
3 Cross references
174 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSSTUG00000010810
Gene Symbol: PDE9A
3 Cross references
179 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSSTUG00000014480
Gene Symbol: PDE9A
3 Cross references
179 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSSTUG00000007799
Gene Symbol: PIK3R2
3 Cross references
185 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSSTUG00000007836
Gene Symbol: PIK3R2
3 Cross references
185 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSSTUG00000017697
Gene Symbol: PIK3R3
3 Cross references
192 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSSTUG00000002823
Gene Symbol: PIK3R3
3 Cross references
192 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSSTUG00000004411
Gene Symbol: PIK3R3
3 Cross references
155 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSSTUG00000005105
Gene Symbol: PIK3R5
3 Cross references
179 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).